Posted by Equitymaster Global financial markets rallied this week and brushed aside a rise in global borrowing costs�while the dollar hit its... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/rXEN7WIlE20/tm.asp
GlaxoSmithKline (GSK) Consumer Healthcare Ltd today reported a 19.97 per cent increase in its standalone net profit at Rs 163.66 crore for the... ...http://www.business-standard.com/article/pti-stories/gsk-consumer-healthcare-q3-profit-up-20-pc-at-rs-163-66-cr-118021200942_1.html
LONDON (Reuters) - GlaxoSmithKline has won another reprieve for its blockbuster Advair lung drug after U.S. regulators delayed approval of a... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/qI5cQTuuNdU/drugmaker-gsk-wins-fresh-advair-reprieve-as-novartis-copy-delayed-idINKBN1FS12J
LONDON (Reuters) - GlaxoSmithKline said on Wednesday its earnings could slip this year, after a better-than-expected performance in the fourth... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/2vLI7kPnWJQ/gsk-cautious-on-2018-as-drug-competition-looms-after-fourth-quarter-beats-idINKBN1FR1PW
Please note that a meeting of the Board of Directors of the Company will be held on Monday, February 12, 2018 at 2.00 p.m. at the Corporate Office... ...http://www.moneycontrol.com/news/announcements/gsk-consumer-healthcare-to-consider-december-quarter-resultsfebruary-12-2018_10457701.html
Advair Diskus 500/50mcg is a...